The impact of SPC Manufacturing Waiver on jobs, competitiveness & patient access to medicines

16^th Biosimilar Medicines Conference

14^th Legal Affairs Conference

17^th Regulatory and Scientific Affairs Conference

11^th Medicines for Europe Pharmacovigilance Conference

IGBA 2017 achievements – Adrian van den Hoven

Life Science Industry Coalition Position paper

How come that biosimilar medicines are still heavily debated today?

What is needed to familiarize oncologists with biosimilar medicines?

What is the role of clinical trials in biosimilar development?